Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Oncology

Topics

Physics

Optics

Medicine

Dentistry

Surgery

Show all topics

DOI

10.1016/s1470-2045(10)70290-4

License

CC-BY

Other Formats

PDF